Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02395367Completed

Prospective, Observational, Real-world Oral Malignant Tumors Study

Role: lead

NCT06574815Not ApplicableCompleted

Effects of the SIS Membrane on GBR and Early Loading of Maxillary Anterior Dental Implants

Role: lead

NCT06469892Completed

Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring

Role: lead

NCT05530252Phase 4Completed

Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis

Role: lead

All 4 trials loaded